<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03091166</url>
  </required_header>
  <id_info>
    <org_study_id>PD-CS-2016</org_study_id>
    <nct_id>NCT03091166</nct_id>
  </id_info>
  <brief_title>Effect of Perioperative Dexmedetomidine Administration on Outcome in Cardiac Surgery Patients</brief_title>
  <official_title>The Effect of Prophylactic Dexmedetomidine Administration on the Outcome in Patients Undergoing Surgery With Cardiopulmonary Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation of effect of perioperative Dexmedetomedine administration on mortality, length
      of ICU and hospital stay, delirium onset, major adverse cardiac and cerebrovascular events,
      acute kidney injury in cardiac surgery patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Actual">April 2019</completion_date>
  <primary_completion_date type="Actual">April 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>30DM</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>30-day mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Delirium</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Postoperative delirium</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VIS</measure>
    <time_frame>5 days after surgery</time_frame>
    <description>Vasoactive- Inotropic Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACCE</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Major adverse cardiac and cerebrovascular events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subsyndromal delirium</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Subsyndromal postoperative delirium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AKI</measure>
    <time_frame>7 days after surgery</time_frame>
    <description>Acute kidney injury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU-LOS</measure>
    <time_frame>7 days after surgery</time_frame>
    <description>Length of ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>H-LOS</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Hospital length of stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">169</enrollment>
  <condition>Patient Outcome Assessment</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No Dexmedetomidine</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>Dexdor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed agreement

          -  Elective surgery

          -  Use of CPB

        Exclusion Criteria:

          -  Previous prolonged immobilization

          -  Reoperation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valery Likhvantsev, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moscow Regional Clinical and Research Institute, Moscow, Russia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</name>
      <address>
        <city>Moscow</city>
        <zip>129110</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>March 21, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <last_update_submitted>April 10, 2019</last_update_submitted>
  <last_update_submitted_qc>April 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</investigator_affiliation>
    <investigator_full_name>Oleg A. Grebenchikov</investigator_full_name>
    <investigator_title>senior researcher</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

